Press Release: Noveome : Noveome Biotherapeutics Completes Dosing of First Baby in Clinical Trial for Treatment of Necrotizing Enterocolitis

The NEC Bell Stage 2a-diagnosed baby completed 10 days of treatment, as well as the required 2-week and 1-month post-treatment follow-up visits. PITTSBURGH, PA, UNITED STATES, November 14, 2024 /⁨EINPresswire.com⁩/ -- Noveome Biotherapeutics, Inc., a ...